"Linking Ubiquitin Research to Drug Discovery"

Ubiquigent - E1 Activating Enzymes

ubiquigent-logo-solid-purple-2022.png

E1 activating enzymes initiate the activation and conjugation of ubiquitin and ubiquitin-like modifiers (UBLs) in a cascade of events that modifies substrate proteins resulting in proteasomal or lysosomal degradation, changes in intracellular localization, activity or other signalling events.

To date eight E1 enzymes have been identified, two characterized from the human genome comprise three domains; an adenylation domain which binds ATP and ubiquitin, a catalytic cysteine domain (CCD) which binds activated ubiquitin, and a C-terminal ubiquitin-fold domain (Ufd) which recruits specific E2 conjugating enzymes. E1 enzymes utilise ATP to activate the terminal glycine residue of ubiquitin/UBL generating a covalent thioester linkage between ‘activated’ ubiquitin/UBL and the E1 enzyme itself. Ubiquitin/UBL is then transferred to the sulphydryl group of the active-site cysteine on an E2 conjugating enzyme in a transthiolation reaction.

Catalog Number Product Name Size Datasheet
UBI-61-0001-010 UBE1 [6His-tagged] 10 ug Datasheet
UBI-61-0001-010 UBE1 [6His-tagged] 50 ug Datasheet
UBI-61-0002-010 UBA6 [6His-tagged] 10 ug Datasheet
UBI-61-0002-010 UBA6 [6His-tagged] 50 ug Datasheet
UBI-61-0005-010 SAE1 [GST-tagged] / SAE2 [6His-tagged] 10 ug Datasheet
UBI-61-0005-010 SAE1 [GST-tagged] / SAE2 [6His-tagged] 50 ug Datasheet
UBI-61-0006-010 APP-BP1 [untagged] / UBA3 [untagged] 10 ug Datasheet
UBI-61-0006-010 APP-BP1 [untagged] / UBA3 [untagged] 50 ug Datasheet
UBI-61-0007-010 UBA7 [6His-tagged] 10 ug Datasheet
UBI-61-0007-010 UBA7 [6His-tagged] 50 ug Datasheet
UBI-61-0008-010 ATG7 [6His-tagged] 10 ug Datasheet
UBI-61-0008-010 ATG7 [6His-tagged] 50 ug Datasheet